A bio-analytical hydrophilic interaction LC-MS/MS method for the simultaneous quantification of omeprazole and lansoprazole in human plasma in support of a pharmacokinetic omeprazole study in children

J Sep Sci. 2010 Mar;33(6-7):939-47. doi: 10.1002/jssc.200900590.

Abstract

A hydrophilic interaction LC method with MS/MS was developed and validated for the simultaneous quantification of omeprazole and lansoprazole in human plasma. Chromatographic separation was achieved on a Betasil silica column using a high organic mobile phase (eluent A: ACN/formic acid 997.5:2.5 v/v; eluent B: water/formic acid 997.5:2.5 v/v) and gradient elution. The mass spectrometer was operated in the Multiple Reaction Monitoring mode. Prior to chromatography, liquid-liquid extraction with ethyl acetate was used and the organic layer was diluted with ACN, allowing direct injection on column. The method showed acceptable linearity, high precision (RSD%<10.5%), accuracy (88.9-109.3%) and selectivity in the two concentration ranges studied: 1.5-100 and 5-2000 ng/mL. The LOQ was established at 1.5 and 5 ng/mL for the two concentration ranges. Lack of variability in matrix effects was demonstrated and mean extraction recovery for omeprazole and lansoprazole was determined in the low (56.3-67.7%) and high (45.3-44.3%) concentration range, respectively. Additionally, plasma samples were found to be stable after three freeze-thaw cycles and for at least 15 h after extraction. This assay was successfully applied to a pharmacokinetic omeprazole study in children with cerebral palsy and mental retardation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • 2-Pyridinylmethylsulfinylbenzimidazoles / blood*
  • 2-Pyridinylmethylsulfinylbenzimidazoles / pharmacokinetics
  • Anti-Ulcer Agents / blood*
  • Anti-Ulcer Agents / pharmacokinetics
  • Chromatography, Liquid / methods*
  • Humans
  • Lansoprazole
  • Limit of Detection
  • Omeprazole / blood*
  • Omeprazole / pharmacokinetics
  • Reference Standards
  • Reproducibility of Results
  • Tandem Mass Spectrometry / methods*

Substances

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Anti-Ulcer Agents
  • Lansoprazole
  • Omeprazole